Detalhe da pesquisa
1.
TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate.
Cell
; 182(2): 297-316.e27, 2020 07 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32619424
2.
Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation.
Nat Immunol
; 22(2): 240-253, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33432228
3.
Untangling the Web of Lymphoma Somatic Mutations.
Cell
; 171(2): 270-272, 2017 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28985559
4.
Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture.
Nature
; 589(7841): 299-305, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33299181
5.
Multi-tiered Reorganization of the Genome during B Cell Affinity Maturation Anchored by a Germinal Center-Specific Locus Control Region.
Immunity
; 45(3): 497-512, 2016 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27637145
6.
The new frontier of epigenetic heterogeneity in B-cell neoplasms.
Curr Opin Hematol
; 24(4): 402-408, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28375986
7.
ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis.
Cancer Cell
; 42(4): 583-604.e11, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38458187
8.
An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas.
Cancer Discov
; 13(1): 216-243, 2023 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36264161
9.
BTG1 mutation yields supercompetitive B cells primed for malignant transformation.
Science
; 379(6629): eabj7412, 2023 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36656933
10.
BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL.
Cancer Discov
; 12(8): 1922-1941, 2022 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35658124
11.
SETD2 Haploinsufficiency Enhances Germinal Center-Associated AICDA Somatic Hypermutation to Drive B-cell Lymphomagenesis.
Cancer Discov
; 12(7): 1782-1803, 2022 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35443279
12.
Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence.
Cancer Discov
; 11(6): 1542-1561, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33500244
13.
Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response.
Cancer Cell
; 37(5): 655-673.e11, 2020 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32396861
14.
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing.
Nat Cancer
; 1: 653-664, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33569544
15.
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma.
Cancer Discov
; 10(3): 440-459, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31915197
16.
ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis.
Cancer Cell
; 42(4): 720-722, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38593783
17.
Rational Targeting of Cooperating Layers of the Epigenome Yields Enhanced Therapeutic Efficacy against AML.
Cancer Discov
; 9(7): 872-889, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31076479
18.
Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition.
Cancer Discov
; 9(4): 546-563, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30705065
19.
Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth.
J Clin Invest
; 128(10): 4397-4412, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30024860
20.
AICDA drives epigenetic heterogeneity and accelerates germinal center-derived lymphomagenesis.
Nat Commun
; 9(1): 222, 2018 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29335468